IDRSF (IDRSF) Stock Price & Analysis
IDRSF (IDRSF) rose 0.48% to USD 6.27 as of September 9, 2026 at 21:22 UTC, according to Nexqual real-time market data.
IDRSF last closed at USD 6.27; the session ranged USD 4.4–4.4 on volume of 250 shares. Market capitalization is —, with a 52-week range of USD 3.3–8.19 (PNK). Source: Nexqual, September 9, 2026 at 21:22 UTC.
Key Statistics (as of September 9, 2026 at 21:22 UTC)
| Price | USD 6.27 |
|---|---|
| Change | ▲ 0.48% (up) |
| Previous Close | USD 6.27 |
| Open | USD 6.27 |
| Day Range | USD 4.4 – 4.4 |
| 52-Week Range | USD 3.3 – 8.19 |
| Volume | 250 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (IDRSF)
Nexqual's technical model rates IDRSF "SELL" based on 2 bullish and 5 bearish signals across 126 daily candles, as of September 9, 2026 at 21:22 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 24.48 (oversold) |
| vs SMA50 | Below (USD 7.44) |
| MACD | -0.31 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| UCBJY | UCB S.A. | USD 118.75 | ▼ 2.96% |
| GNMSF | Genmab A/S | USD 329.25 | ▲ 0% |
| CMXHF | CSL Ltd. | USD 126.18 | ▼ 0.48% |
| GNNSF | Genscript Biotech Corp | USD 4 | ▲ 0% |
| IVBXF | Innovent Biologics Inc. | USD 13.19 | ▲ 0.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 21:22 UTC. This page is informational and not investment advice.